Single Dose of Dexamethasone in Femur Fractures

Sponsor
Cork University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01550146
Collaborator
University of Bristol (Other)
40
1
2
36
1.1

Study Details

Study Description

Brief Summary

Fracture neck of femur is a common cause of hospital admission in the elderly and requires operative fixation.

Dexamethasone has the potential of inhibiting cortisol secretion. In addition, preoperative glucocorticoids improve analgesia and decrease opioid consumption with reduction in associated side effects in a variety of clinical settings.

The investigators hypothesis was that a single dose of preoperative dexamethasone enhance postoperative analgesia and attenuates the inflammatory response in patients undergoing operative fixation of fractured neck of femur, in a prospective, randomized, placebo controled trial.

Condition or Disease Intervention/Treatment Phase
  • Drug: Dexamethasone acetate
  • Drug: Placebo
Phase 4

Detailed Description

Having obtained ethical approval and written informed consent from each, 40 patients scheduled to undergo operative fixation of fractured neck of femur will be randomized using sealed envelopes to two groups.

Patients in the Dexamethasone group receive a single dose of 0.1 mg/kg dexamethasone iv. preoperative, patients in the Placebo group receive the same amount of Normal Saline. The anaesthetic technique is standardized, salive samples, blood samples are taken and pain scores are measured on a visual analog scale postoperatively at several timepoints.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of a Single Dose of Dexamethasone in Patients Undergoing Operative Fixation of Proximal Femur Fracture
Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Jan 1, 2012
Anticipated Study Completion Date :
Jul 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dexamethasone, 0.1 mg/kg

The patients in the Dexamethasone group get iv 0.1 mg/kg dexamethasone preoperative.

Drug: Dexamethasone acetate
iv. dexamethasone 0.1 mg/kg

Placebo Comparator: Placebo

In the Placebo group the patients get 0.1 ml/kg normal saline.

Drug: Placebo
iv. Normal Saline 0.1 ml/kg

Outcome Measures

Primary Outcome Measures

  1. Visual analogue pain scale at rest and on movement postoperatively [Postoperative in recovery, 6, 12, 24, 48, 72 hourly]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • above 65 years

  • ASA I-III patients

Exclusion Criteria:
  • patient refusal

  • outside age range

  • coagulation disorders

  • depression

  • Cushing syndrome

  • endocrine disorders

  • corticosteroid treatment in the last 4 month

  • head injury or associated injuries

  • Mini Mental Scores < 25

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cork University Hospital Cork Ireland

Sponsors and Collaborators

  • Cork University Hospital
  • University of Bristol

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Szilard Szucs, Clinical Tutor in Anaesthesia, Cork University Hospital
ClinicalTrials.gov Identifier:
NCT01550146
Other Study ID Numbers:
  • 14640820
First Posted:
Mar 9, 2012
Last Update Posted:
Mar 9, 2012
Last Verified:
Mar 1, 2012
Keywords provided by Szilard Szucs, Clinical Tutor in Anaesthesia, Cork University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2012